geranylgeraniol has been researched along with Mesothelioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hiroshima, K; Jiang, Y; Kawamura, K; Kobayashi, H; Okamoto, S; Sekine, I; Shimada, H; Shingyoji, M; Tada, Y; Tagawa, M; Takiguchi, Y; Tatsumi, K | 1 |
1 other study(ies) available for geranylgeraniol and Mesothelioma
Article | Year |
---|---|
Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions.
Topics: Apoptosis; cdc42 GTP-Binding Protein; Cell Line, Tumor; Diphosphonates; Diterpenes; DNA Topoisomerases, Type II; Farnesol; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Leucine; Mesothelioma; Myeloid Cell Leukemia Sequence 1 Protein; Protein Prenylation; rab GTP-Binding Proteins; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein; RNA, Small Interfering; S Phase; Signal Transduction; Transferases; Zoledronic Acid | 2014 |